Prostate Cancer
Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml - Abstract
January 23, 2012
NutriTRAILomics in prostate cancer: Time to have two strings to one's bow - Abstract
January 23, 2012
Comparative analysis of three risk assessment tools in Australian patients with prostate cancer - Abstract
January 20, 2012
Clinical results after high-dose intensity-modulated radiotherapy for high-risk prostate cancer - Abstract
January 20, 2012
MR imaging of treated prostate cancer - Abstract
January 20, 2012
Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer - Abstract
January 20, 2012
Early experience in MRI-guided therapies of prostate cancer: HIFU, laser and photodynamic treatment - Abstract
January 19, 2012
Prostate cancer: Localizing the cancer in patients with persistent negative biopsies - Abstract
January 19, 2012
Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone - Abstract
January 19, 2012
Advanced prostate cancer: Reinforcing the strings between inflammation and the metastatic behavior - Abstract
January 19, 2012